High-throughput Mutational Surveillance of the SARS-CoV-2 Spike Gene
Özkan, E.; Strobl, M. M.; Novatchkova, M.; Yelagandula, R.; Albanese, T. G.; Triska, P.; Endler, L.; Penz, T.; Patocka, T.; Felsenstein, V.; Vogt, A.; Tamir, I.; Seitz, T.; Foedinger, M.; Herwig, R.; Indra, A.; Schmid, D.; Bock, C.; Bergthaler, A.; Stark, A.; Allerberger, F.; Elling, U.; Cochella, L.
10.1101/2021.07.22.21259587 medRxivShow abstract
SARS-CoV-2 has evolved rapidly towards higher infectivity and partial immune escape over the course of the pandemic. This evolution is driven by the enormous virus population, that has infected close to 200 million people by now. Therefore, cost effective and scalable methods are needed to monitor viral evolution globally. Mutation-specific PCR approaches have become inadequate to distinguish the variety of circulating SARS-CoV-2 variants and are unable to detect novel ones. Conversely, whole genome sequencing protocols remain too labor- and cost-intensive to monitor SARS-CoV-2 at the required density. By adapting SARSeq we present a simple, fast, and scalable S-gene tiling pipeline for focused sequencing of the S-gene encoding for the spike protein. This method reports on all sequence positions with known importance for infectivity and immunity, yet scales to >20K samples per run. S-gene tiling is used for nationwide surveillance of SARS-CoV-2 at a density of 10% to 50% of all cases of infection in Austria. SARSeq S-tiling uncovered several infection clusters with variants of concern such as the biggest known cluster of Beta/B.1.351 outside Africa and successfully informed public health measures in a timely manner, allowing their successful implementation. Our close monitoring of mutations further highlighted evolutionary constraints and freedom of the spike protein ectodomain and sheds light on foreseeable evolutionary trajectories.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis 97%
- SARSeq, a robust and highly multiplexed NGS assay for parallel detection of SARS-CoV2 and other respiratory infections 97%
- A Multiplexed, Next Generation Sequencing Platform for High-Throughput Detection of SARS-CoV-2 97%
Similar papers in this journal
Similar papers in this journal
- Viral evolution prediction identifies broadly neutralizing antibodies against existing and prospective SARS-CoV-2 variants 95%
- Infection cycle and phylogeny of the Polinton-like virus Phaeocystis globosa virus virophage-14T 95%
- Rapid heuristic inference of antibiotic resistance and susceptibility by genomic neighbor typing 95%
Similar papers in this journal
- High number of SARS-CoV-2 persistent infections uncovered through genetic analysis of samples from a large community-based surveillance study 96%
- Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades 95%
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.